Stocks · Health care · Pharmaceutical Preparations

Acrivon Therapeutics, Inc.

ACRV Clue Score43
United States Fiscal year ends December CIK 0001781174 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Adam D. Levy
14 Jan 2026
Chief Financial Officer
Buy
8,832
$1.70
$15.00K
Peter Blume-Jensen
14 Jan 2026
President and CEO
Buy
49,000
$1.68
$82.12K
Eric Devroe
13 Jan 2026
Chief Operating Officer
Buy
10,000
$1.72
$17.22K

What was left out

Form 4 filings counted 63
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 4,614,977
History held since 16 Nov 2022